Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework-Reference-Cited by-同舟云学术

Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework

Published:2022-07 Issue:S2 Volume:25 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc.

Author:

Renaud Françoise¹^ORCID,Mofenson Lynne M.²,Bakker Charlotte³,Dolk Helen⁴,Leroy Valeriane⁵^ORCID,Namiba Angelina⁶,Sahin Leyla⁷,Shapiro Roger⁸,Slogrove Amy⁹^ORCID,Thorne Claire¹⁰,Vicari Marissa¹¹,Low‐Beer Daniel¹,Doherty Meg¹

Affiliation:

1. Department of Global HIV Hepatitis and Sexually Transmitted Infections Programmes World Health Organization Geneva Switzerland

2. Research Department Elizabeth Glaser Pediatric AIDS Foundation Washington DC USA

3. Seconded National Expert Translational Sciences Office Scientific Evidence Generation Department European Medicines Agency Amsterdam The Netherlands

4. EUROmediCAT Institute for Nursing and Health Research Ulster University Jordanstown United Kingdom

5. Centre d'Epidémiologie et Recherche en Santé des POPulations (CERPOP) Inserm, Université de Toulouse Paul Sabatier Toulouse France

6. 4M Network of Mentor Mothers London UK

7. Division of Pediatrics and Maternal Health US Food and Drug Administration Silver Spring Maryland USA

8. Harvard T.H. Chan School of Public Health Boston Massachusetts USA

9. Department of Paediatrics and Child Health Faculty of Medicine and Health Sciences Stellenbosch University Worcester South Africa

10. Great Ormond Street Institute of Child Health University College London London UK

11. HIV Programmes and Advocacy Department International AIDS Society Geneva Switzerland

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25922

Reference36 articles.

1. Enhanced and Timely Investigation of ARVs for Use in Pregnant Women

2. Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus

3. Teratogenicity risk of antiretroviral therapy in pregnancy

4. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception

5. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study;BMC Infectious Diseases;2024-09-02

2. Safety Data Timelines for Pregnant Individuals With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy;Clinical Infectious Diseases;2024-05-06

3. Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential;Expert Review of Anti-infective Therapy;2024-03-27

4. Setting the research agenda: involving parents in research on children who are HIV‐free;Journal of the International AIDS Society;2023-10

5. Crucial need for improved pharmacovigilance in pregnancy;The Lancet HIV;2023-09